A clinical study to study the drug Seenthil Sarkkarai on Neerizhivu
- Conditions
- Health Condition 1: null- Iya Neerizhivu
- Registration Number
- CTRI/2018/01/011497
- Lead Sponsor
- Dr S Neelavathi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Type 2 diabetes mellitus
If yes in any of three
FBS above 110 mg per dl and below and equal 250mg per dl or
PPBS above 160 mg per dl and below and equal 350mg per dl
HbA1c above 6.4 and below 10
Persistent cases of COPD as per the standard key indicators for assessment
FEV1 between above 50 percentage and below 80 percentage of the predicted value
Willing to give blood sample for the investigations
Patients who are mono therapy alone
Age below 40 and above 70
Type 1 diabetes mellitus
If yes in any of three
FBS below 109 mg per dl and above and equal 251 mg per dl or
PPBS below 159 mg per dl and above and equal 351 mg per dl
HbA1c below 6.3 and above 10.1
FEV1 below 50 percentage and above 80 percentage of the predicted value
Pregnant woman and plan to pregnant six months
Lactating mother
Chronic kidney disease or Renal failure
Corticosteroid therapy
Chronic active hepatitis or cirrhosis or ascites
Multisystem involvement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The therapeutic efficacy of trial drug Seenthil Sarkkarai on IYA NEERIZHIVUTimepoint: 90 days
- Secondary Outcome Measures
Name Time Method Evaluation of Siddha diagnostic parametersTimepoint: 90 days